These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977 [TBL] [Abstract][Full Text] [Related]
4. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation]. Bujía J; Holly A; Kim C; Schilling V; Kastenbauer E Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881 [TBL] [Abstract][Full Text] [Related]
5. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma. Sasaki H; Huang CC Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866 [TBL] [Abstract][Full Text] [Related]
6. [Expression of 4F2-activation antigen in middle ear cholesteatoma]. Holly A; Bujía J; Sanchez-Madrid F Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083 [TBL] [Abstract][Full Text] [Related]
7. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343 [TBL] [Abstract][Full Text] [Related]
8. Expression patterns of cytokeratins in retraction pocket cholesteatomas. Kim HJ; Tinling SP; Chole RA Laryngoscope; 2001 Jun; 111(6):1032-6. PubMed ID: 11404616 [TBL] [Abstract][Full Text] [Related]
9. The nature of the epithelium in acquired cholesteatoma. Lee RJ; Mackenzie IC; Hall BK; Gantz BJ Clin Otolaryngol Allied Sci; 1991 Apr; 16(2):168-73. PubMed ID: 1712679 [TBL] [Abstract][Full Text] [Related]
10. [Interleukin-1-containing cells in cholesteatoma of the middle ear]. Schilling V; Bujia J; Negri B; Kastenbauer E Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549 [TBL] [Abstract][Full Text] [Related]
12. Cholesteatoma of the middle ear in human patients. An ultrastructural study. Schaper J; van de Heyning J Arch Otolaryngol; 1976 Nov; 102(11):663-8. PubMed ID: 985197 [TBL] [Abstract][Full Text] [Related]
15. [Expression of calgranulin A and B in middle ear cholesteatoma]. Holly A; Bujía J; Lempart K; Serge M Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019 [TBL] [Abstract][Full Text] [Related]
16. [DNA cytometric studies of cholesteatoma of the middle ear]. Bollmann R; Knopp U; Tolsdorff P HNO; 1991 Aug; 39(8):313-4. PubMed ID: 1938497 [TBL] [Abstract][Full Text] [Related]
18. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis. Van Blitterswijk CA; Grote JJ; Lutgert RW; Hesseling SC; Out CJ; Van Muijen GN; Fransen JA Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048 [TBL] [Abstract][Full Text] [Related]